Non-Hodgkin lymphoma patient who was working with Roundup is suing Monsanto


Roundup Lawsuit
July 25, 2018 Categories: Product Liability, Settlements and Lawsuits

Pin It

Non-Hodgkin lymphoma patient who was working with Roundup is suing Monsanto

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma.
People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country.
Case of DeWayne Johnson against Monsanto went to trial in San Francisco, California on July 09, 2018. Monsanto is accused of hiding the dangers of its popular Roundup® products.

Nearly 4,000 people across the country claim Roundup® made them sick, and expect to take their case against Monsanto to trial.
If you or your loved one was diagnosed with this terrible cancer after being exposed to Roundup®, you may be eligible to file a lawsuit against its manufacturer, Monsanto, and receive significant financial compensation for your pain and suffering.

More information: Roundup® lawsuits are being filed across the country

Your Comment

Recent Updates

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

July 25, 2018

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

July 18, 2018

Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...

July 17, 2018